Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA proposes rule for sponsors to report falsified data within 45 days

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration is proposing to amend its regulations to require sponsors to report information pertaining to any individual that has or may have engaged in falsification of data in studies involving human or animal subjects. Such information would need to be reported “promptly”, but no later than 45 calendar days after the sponsor became aware of the information, according to the proposed rule outlined in the 19 February Federal Register1.

Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS115075

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel